PMParv Mehta

Parv Mehta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Parv Mehta has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cerebrospinal Fluid Shunts: An Updated Radiologic Review of Devices, Malfunctions, and Complications

    by Annie Singh, Ishaan Singh, Nikita Goyal, Pranjal Rai, Parv Mehta, Amit Agarwal

    Cerebrospinal fluid (CSF) shunt devices are essential for managing hydrocephalus by diverting excess CSF from the ventricles and thereby reducing symptoms such as headaches, vision problems, and cognitive deficits. A typical shunt system includes a ventricular catheter, reservoir, valve, and distal catheter. These components are usually made of silastic and radiopaque materials for durability and imaging. The systems also include enhancements like programmable valves, anti-siphon devices, and gravitational units to improve function. Shunts are categorized by outflow destination (ventriculoperitoneal, ventriculoatrial, ventriculopleural, and lumboperitoneal) or by valve type (fixed or adjustable). While fixed valves have been the standard of care for years, adjustable valves allow non-invasive pressure changes, reducing the need for repeated surgeries. Radiographic evaluation of shunt placement and function is crucial in clinical care. Common complications associated with the use of such systems include mechanical failure (e.g., obstruction, fracture, and migration), infections, functional issues, and metastasis, which often require surgical revision. This paper offers an overview of CSF shunts, including their structure, functions, imaging characteristics, and potential complications. Additionally, we have summarized the imaging characteristics of currently available programmable shunt devices and briefly discussed other types of commonly used drainage devices along with their specific indications. A thorough understanding of these aspects is critical for effective diagnosis, treatment, and management of hydrocephalus and its related challenges.


  • Open Access

    Imaging Findings Post-Stereotactic Radiosurgery for Vestibular Schwannoma: A Primer for the Radiologist

    by Girish Bathla, Parv M. Mehta, John C. Benson, Amit K. Agrwal, Neetu Soni, Michael J. Link, Matthew L. Carlson, John I. Lane

    Non-invasive tumor control of vestibular schwannomas through stereotactic radiosurgery allows for high rates of long-term tumor control and has been used primarily for small and medium-sized vestibular schwannomas. The post-treatment imaging appearance of the tumor, temporal patterns of growth and treatment response, as well as extra-tumoral complications can often be both subtle or confusing and should be appropriately recognized. Herein, the authors present an imaging-based review of expected changes, as well as associated complications related to radiosurgery for vestibular schwannomas. ABBREVIATIONS: FSRT: Fractionated stereotactic radiotherapy, ISRS: international stereotactic radiosurgery, MPNST: Malignant peripheral nerve sheath tumor, SRS: Stereotactic radiosurgery, VS: Vestibular schwannoma.


  • Open Access

    High-Grade Astrocytoma with Piloid Features: A Dual Institutional Review of Imaging Findings of a Novel Entity

    by Neetu Soni, Amit Agarwal, Pranav Ajmera, Parv Mehta, Vivek Gupta, Mukta Vibhute, Maria Gubbiotti, Ian T. Mark, Steven A. Messina, Suyash Mohan, et al.

    SUMMARY: High-grade astrocytoma with piloid features (HGAP) is a recently identified brain tumor characterized by a distinct DNA methylation profile. Predominantly located in the posterior fossa of adults, HGAP is notably prevalent in individuals with neurofibromatosis type 1. We present an image-centric review of HGAP and explore the association between HGAP and neurofibromatosis type 1. Data were collected from 8 HGAP patients treated at two tertiary care institutions between January 2020 and October 2023. Demographic details, clinical records, management, and tumor molecular profiles were analyzed. Tumor characteristics, including location and imaging features on MR imaging, were reviewed. Clinical or imaging features suggestive of neurofibromatosis 1 or the presence of NF1 gene alteration were documented. The mean age at presentation was 45.5 years (male/female = 5:3). Tumors were midline, localized in the posterior fossa (n = 4), diencephalic/thalamic (n = 2), and spinal cord (n = 2). HGAP lesions were T1 hypointense, T2-hyperintense, mostly without diffusion restriction, predominantly peripheral irregular enhancement with central necrosis (n = 3) followed by mixed heterogeneous enhancement (n = 2). Two NF1 mutation carriers showed signs of neurofibromatosis type 1 before HGAP diagnosis, with one diagnosed during HGAP evaluation, strengthening the HGAP-NF1 link, particularly in patients with posterior fossa masses. All tumors were IDH1 wild-type, often with ATRX, CDKN2A/B, and NF1 gene alteration. Six patients underwent surgical resection followed by adjuvant chemoradiation. Six patients were alive, and two died during the last follow-up. Histone H3 mutations were not detected in our cohort, such as the common H3K27M typically seen in diffuse midline gliomas, linked to aggressive clinical behavior and poor prognosis. HGAP lesions may involve the brain or spine and tend to be midline or paramedian in location. Underlying neurofibromatosis type 1 diagnosis or imaging findings are important diagnostic cues.


  • Unpacking the CNS Manifestations of Epstein-Barr Virus: An Imaging Perspective

    by N. Soni, M. Ora, R. Singh, P. Mehta, A. Agarwal, G. Bathla

    SUMMARY: Epstein-Barr virus is a ubiquitous herpesvirus that may cause both infective (encephalitis, meningitis, and so forth) and postinfection inflammatory (such as Guillain-Barré syndrome, acute disseminated encephalomyelitis) manifestations in the CNS. Diagnosis of Epstein-Barr virus–related CNS pathologies is often complicated due to a nonspecific clinical presentation and overlap with other infectious and noninfectious causes, both clinically and on imaging. The Epstein-Barr virus is also implicated in several lymphoproliferative disorders in both immunocompromised and immunocompetent hosts. MR imaging is preferred for evaluating the extent of involvement and monitoring therapy response, given its high sensitivity and specificity, though imaging findings may be nonspecific. Herein, we review the imaging spectrum of Epstein-Barr virus–associated CNS disorders.


  • Open Access

    Advances in Acute Ischemic Stroke Treatment: Current Status and Future Directions

    by G. Bathla, P. Ajmera, P.M. Mehta, J.C. Benson, C.P. Derdeyn, G. Lanzino, A. Agarwal, W. Brinjikji

    SUMMARY: The management of acute ischemic stroke has undergone a paradigm shift in the past decade. This has been spearheaded by the emergence of endovascular thrombectomy, along with advances in medical therapy, imaging, and other facets of stroke care. Herein, we present an updated review of the various stroke trials that have impacted and continue to transform stroke management. It is critical for the radiologist to stay abreast of the ongoing developments to provide meaningful input and remain a useful part of the stroke team.